| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | E.coli-derived human IFT20 recombinant protein (Position: M1-K132) was used as the immunogen for the IFT20 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
IFT20 Antibody / Intraflagellar transport protein 20 homolog is a anti-IFT20 Rabbit antibody Polyclonal (rabbit origin) supplied in Lyophilized format. Recommended for workflows such as Western blot (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Flow cytometry (FACS), ELISA with listed reactivity in Human, Mouse, Rat. Reported localization: Cytoplasm.
Key elements and design rationale
- Target: IFT20
- Antibody details: Rabbit, Polyclonal (rabbit origin), isotype Rabbit IgG
- Format: Lyophilized
- Applications (as listed): WB, IHC, IF, FACS, ELISA
Biological background
Functionally, IFT20 antibody identifies a 132-amino-acid protein localized to the Golgi apparatus and the base of cilia. IFT20 associates with the IFT-B complex and interacts with proteins such as IFT57, IFT88, and GMAP210 to coordinate transport of ciliary cargo from the Golgi to the basal body. It plays essential roles in ciliogenesis, ciliary membrane protein sorting, and Hedgehog signaling. IFT20 functions both in ciliated cells, such as renal epithelial cells and photoreceptors, and in non-ciliated cells, where it contributes to vesicle trafficking and immune synapse formation.
The IFT20 gene is located on chromosome 17q25.3 and is ubiquitously expressed in tissues with active ciliary assembly, including kidney, lung, retina, and brain. Expression is dynamically regulated during cell cycle progression and development, reflecting its importance in signaling and organelle biogenesis.
Pathologically, mutations or loss of IFT20 disrupt cilium formation and function, leading to a spectrum of ciliopathies such as polycystic kidney disease, retinal degeneration, and developmental disorders. Altered expression may also affect immune function, as IFT20 participates in T-cell receptor recycling. Research using IFT20 antibody supports studies in cilia biology, vesicular trafficking, and developmental signaling pathways.
IFT20 antibody is validated for western blotting, immunofluorescence, and immunohistochemistry to detect ciliary transport proteins.
Structurally, Intraflagellar transport protein 20 homolog is a small coiled-coil protein that integrates into the IFT-B complex. Its N-terminal region anchors it to the Golgi, while the C-terminal region mediates interactions with IFT components. This structural configuration enables IFT20 to couple vesicular transport and ciliary assembly. This antibody aids in investigating IFT20's role in cellular signaling, ciliogenesis, and trafficking fidelity.
Research relevance and current trends
- Connecting protein-level changes to phenotype using orthogonal readouts (genetic perturbation, transcriptomics, imaging).
- Considering isoforms and post-translational regulation when interpreting protein-level changes.
- Comparing results across species and model systems with matched controls.
Common research applications
- Western blotting: compare relative abundance and activation-state changes across conditions.
- Immunofluorescence: visualize subcellular distribution and cell-to-cell heterogeneity.
- Immunohistochemistry: map target signal in tissue context and compare regions/phenotypes.
- Flow cytometry: quantify target-positive populations and signal shifts at single-cell resolution.
- ELISA: support antibody-based quantification in assay formats where applicable.
Interpret changes in signal alongside appropriate controls and, when relevant, in parallel with total-protein or pathway readouts.
Notes for experimental interpretation
- Signal can reflect expression level, isoform composition, and post-translational state; interpret results in the context of your model system and stimuli.
- Species differences and sample matrices can influence epitope recognition; prioritize matched controls and orthogonal confirmation when feasible.
Antibody notes: Polyclonal antibodies recognize multiple epitopes, which can broaden the epitope footprint and may increase sensitivity in some contexts.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
